Janux Therapeutics

1 follower

‌

Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.

Industries

Biotechnology

Headquarters

San Diego, United States

Employees

51-200

Links

Org chart

David Campbell

President & CEO

David Campbell

Collapse

Tighe Reardon

Acting CFO

Andy Meyer

Chief Business Officer

Byron Robinson

Chief Strategy Officer

Charles Winter

CTO

Carolina Caffaro

Executive Director, CMC

Hans Aerni

Senior Director, CMC Analytical Development

Jerry Warren

Senior Director Regulatory Affairs

Lina Ma

Associate Director in Pharmacology

Natalija Van Braeckel Budimir

Director, Immunology

Nick Almaguer

Director, Analytical Development

Sara Walsh

Executive Administrative Assistant to the President and Chief Executive Officer

Sheila Gujrathi, MD

Director Board Of Directors

Yogesh Bramhecha, PhD

Director, Biomarker Discovery

James Pennington

General Counsel

Zachariah McIver

Vice President at Janux Therapeutics

Tommy DiRaimondo

Executive Director, Research & Development

Megan Shannon

Senior Director, Clinical Science

Teams

+29

Research and Development Team

32 members

Advisory Team

8 members

Leadership Team

5 members

Finance and Accounting

6 members

Operations Team

4 members

Regulatory and Development Team

2 members

Similar companies

Relay Therapeutics

1 follower

Eikon Therapeutics

1 follower

Thermo Fisher Scientific

166 followers

Formation Bio

2 followers

Regeneron

94 followers

Agilent Technologies

63 followers

Alexion Pharmaceuticals

34 followers

Charles River Laboratories

11 followers

Cytiva

10 followers

FirstWord Group

2 followers

Merck

216 followers

Explore companies